BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22358992)

  • 1. Irinotecan loaded in eluting beads: preclinical assessment in a rabbit VX2 liver tumor model.
    Rao PP; Pascale F; Seck A; Auperin A; Drouard-Troalen L; Deschamps F; Teriitheau C; Paci A; Denys A; Bize P; de Baere T
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1448-59. PubMed ID: 22358992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model.
    Tanaka T; Nishiofuku H; Hukuoka Y; Sato T; Masada T; Takano M; Gilbert CW; Obayashi C; Kichikawa K
    J Vasc Interv Radiol; 2014 Jul; 25(7):1037-1044.e2. PubMed ID: 24861663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of irinotecan-loaded QuadraSphere microspheres for use in chemoembolization of VX2 liver tumors.
    Tanaka K; Maeda N; Osuga K; Higashi Y; Hayashi A; Hori Y; Kishimoto K; Morii E; Ohashi F; Tomiyama N
    J Vasc Interv Radiol; 2014 Nov; 25(11):1727-35.e1. PubMed ID: 25239839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
    Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
    J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N; Akinwande O; Martin RC
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, safety and pharmacokinetic study of hepatic administration of drug-eluting beads loaded with irinotecan (DEBIRI) followed by intravenous administration of irinotecan in a porcine model.
    Lewis AL; Holden RR; Chung ST; Czuczman P; Kuchel T; Finnie J; Porter S; Foster D
    J Mater Sci Mater Med; 2013 Jan; 24(1):115-27. PubMed ID: 23015264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraarterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rabbit Liver Tumor Model.
    Nishiofuku H; Tanaka T; Fukuoka Y; Sato T; Masada T; Tatsumoto S; Sho M; Yamato I; Yasuda S; Matsushima S; Takano M; Ohbayashi C; Kichikawa K
    J Vasc Interv Radiol; 2017 Mar; 28(3):457-464. PubMed ID: 28041782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.
    Carling U; Dorenberg EJ; Haugvik SP; Eide NA; Berntzen DT; Edwin B; Dueland S; Røsok B
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1532-41. PubMed ID: 25832764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study.
    Fiorentini G; Aliberti C; Tilli M; Mulazzani L; Graziano F; Giordani P; Mambrini A; Montagnani F; Alessandroni P; Catalano V; Coschiera P
    Anticancer Res; 2012 Apr; 32(4):1387-95. PubMed ID: 22493375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
    Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
    Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
    Richardson AJ; Laurence JM; Lam VW
    J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of Combination Intra-arterial Yttrium-90 and Irinotecan Microspheres in the VX2 Rabbit Model.
    Gordon AC; White SB; Yang Y; Gates VL; Procissi D; Harris KR; Zhang Z; Lyu T; Huang X; Dreher MR; Omary RA; Salem R; Lewandowski RJ; Larson AC
    Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1528-1537. PubMed ID: 32533312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
    Iezzi R; Marsico VA; Guerra A; Cerchiaro E; Cassano A; Basso M; Devicienti E; Rodolfino E; Barone C; Bonomo L
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1523-31. PubMed ID: 25799948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome.
    Jones RP; Stättner S; Dunne DF; O'Grady E; Smethurst A; Terlizzo M; Malik HZ; Fenwick SW; Poston GJ
    Eur J Surg Oncol; 2013 Oct; 39(10):1122-8. PubMed ID: 23928482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
    Akinwande O; Scoggins C; Martin RC
    Anticancer Res; 2016 Jul; 36(7):3413-8. PubMed ID: 27354601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases.
    Tang Y; Taylor RR; Gonzalez MV; Lewis AL; Stratford PW
    J Control Release; 2006 Nov; 116(2):e55-6. PubMed ID: 17718969
    [No Abstract]   [Full Text] [Related]  

  • 17. Bradycardia associated with drug-eluting beads loaded with irinotecan (DEBIRI) infusion for colorectal liver metastases.
    Pua U
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):864-6. PubMed ID: 22722719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant capecitabine with hepatic delivery of drug eluting beads in metastatic colorectal cancer.
    Akinwande O; Miller A; Hayes D; O'Hara R; Tomalty D; Martin RC
    Anticancer Res; 2014 Dec; 34(12):7239-45. PubMed ID: 25503155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study.
    Martin RC; Joshi J; Robbins K; Tomalty D; Bosnjakovik P; Derner M; Padr R; Rocek M; Scupchenko A; Tatum C
    Ann Surg Oncol; 2011 Jan; 18(1):192-8. PubMed ID: 20740319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.
    Kaiser J; Thiesen J; Krämer I
    J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.